SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Goldman Sachs Maintains Buy on Moderna, Raises Price Target to $105

Goldman Sachs analyst Salveen Richter maintains Moderna (NASDAQ:MRNA) with a Buy and raises the price target from $63 to $105.

Benzinga · 05/18/2020 17:12

Goldman Sachs analyst Salveen Richter maintains Moderna (NASDAQ:MRNA) with a Buy and raises the price target from $63 to $105.